I won’t be surprised if Peter Smith is appointed as CEO. I think PL wanted to go back to NED role as his personal preference.
DT’s role as consultant is vague and may make sense to bring him as ED and CSO. Him providing inputs and the other Directors nodding their heads is meaningless; conversely if said something as a consultant which got voted down from the BOD is a waste of time and only create angst. Also having the biggest investor as a director when any offers come thru, is better to have him at the table than on the outside like Robinhood trying to fight the good fight.
The company seemed to have a definite purpose and clear comms which all SHs liked.
Just my guess anyway. DYOR.
General Comments / Chat, page-8916
-
- There are more pages in this discussion • 2,200 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.94 |
Change
0.000(0.00%) |
Mkt cap ! $313.4M |
Open | High | Low | Value | Volume |
$1.95 | $1.95 | $1.84 | $647.3K | 344.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 3300 | $1.87 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.94 | 5654 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 3300 | 1.870 |
4 | 46789 | 1.840 |
2 | 6500 | 1.830 |
2 | 649 | 1.820 |
1 | 829 | 1.805 |
Price($) | Vol. | No. |
---|---|---|
1.940 | 5654 | 2 |
1.950 | 7570 | 1 |
1.960 | 1350 | 1 |
1.990 | 4701 | 2 |
1.995 | 10037 | 1 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online